相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and Safety of Guselkumab, an Interleukin-23p 19-Specific Monoclonal Antibody, Through One Year in Biologic-Naive Patients With Psoriatic Arthritis
Iain B. McInnes et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Relation Between Fatigue and ACR Response in Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitor Therapy: A Population-based Cohort Study
Tanja Schjodt Jorgensen et al.
JOURNAL OF RHEUMATOLOGY (2021)
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial
Philip J. Mease et al.
LANCET (2020)
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
Atul Deodhar et al.
LANCET (2020)
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Laure Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study
P. G. Conaghan et al.
RMD OPEN (2020)
Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis
Dafna Gladman et al.
RMD OPEN (2020)
Content validity and psychometric evaluation of Functional Assessment of Chronic Illness Therapy-Fatigue in patients with psoriatic arthritis
David Cella et al.
JOURNAL OF PATIENT-REPORTED OUTCOMES (2019)
Effect of biologics on fatigue in psoriatic arthritis: A systematic literature review with meta-analysis
Thomas Reygaerts et al.
JOINT BONE SPINE (2018)
Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1)
Vibeke Strand et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Fatigue favors in vitro Th1 and Th17-like cell expansion and reduces corticoid sensitivity in MS patients
Helcio Alvarenga-Filho et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016
Ana-Maria Orbai et al.
JOURNAL OF RHEUMATOLOGY (2017)
Psoriatic Arthritis
Christopher T. Ritchlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study
Iain B. McInnes et al.
RHEUMATOLOGY (2017)
Fatigue in psoriasis: a controlled study
I. M. Skoie et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Fatigue as a symptom in psoriasis and psoriatic arthritis: an observational study
A. M. Tobin et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
HOW TO SELECT THE MOST APPROPRIATE CAPILLAROSCOPIC DEVICE: PROS AND CONS
F. Ingegnoli
ANNALS OF THE RHEUMATIC DISEASES (2016)
Fatigue in psoriatic arthritis - a cross-sectional study of 246 patients from 13 countries
Tania Gudu et al.
JOINT BONE SPINE (2016)
Patient-Physician Discordance in Global Assessment in Rheumatoid Arthritis: A Systematic Literature Review With Meta-Analysis
Carole Desthieux et al.
ARTHRITIS CARE & RESEARCH (2016)
Factors Explaining the Discrepancy Between Physician and Patient Global Assessment of Joint and Skin Disease Activity in Psoriatic Arthritis Patients
Lihi Eder et al.
ARTHRITIS CARE & RESEARCH (2015)
Fatigue in chronic inflammation - a link to pain pathways
Karine Louati et al.
ARTHRITIS RESEARCH & THERAPY (2015)
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative
Laure Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
Christopher Ritchlin et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Work Productivity Loss and Fatigue in Psoriatic Arthritis
Jessica A. Walsh et al.
JOURNAL OF RHEUMATOLOGY (2014)
Effect of Certolizumab Pegol on Multiple Facets of Psoriatic Arthritis as Reported by Patients: 24-Week Patient-Reported Outcome Results of a Phase III, Multicenter Study
D. Gladman et al.
ARTHRITIS CARE & RESEARCH (2014)
Mediation Analysis Allowing for Exposure-Mediator Interactions and Causal Interpretation: Theoretical Assumptions and Implementation With SAS and SPSS Macros
Linda Valeri et al.
PSYCHOLOGICAL METHODS (2013)
Biological mechanisms of chronic fatigue
Katrine B. Norheim et al.
RHEUMATOLOGY (2011)
Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment
L. C. Coates et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Longitudinal Analysis of Fatigue in Psoriatic Arthritis
Janice A. Husted et al.
JOURNAL OF RHEUMATOLOGY (2010)
Occurrence and correlates of fatigue in psoriatic arthritis
J. A. Husted et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis
Vinod Chandran et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial
D. D. Gladman et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Classification criteria for psoriatic arthritis - Development of new criteria from a large international study
William Taylor et al.
ARTHRITIS AND RHEUMATISM (2006)
Divergent pro- and Antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation
CA Murphy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Fatigue in cancer patients compared with fatigue in the general United States population
D Cella et al.
CANCER (2002)
分享论文
